Global Plasticizers Market Will Reach USD 17.94 Billion By 2024: Zion Market Research
/
Date08 Dec 2018
Email Print Friendly Share New York, NY, Dec. 07, 2018 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Plasticizers Market by... Read More →
Novartis data demonstrates consistent efficacy and tolerability of Kisqali® combination therapy in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease
/
Date08 Dec 2018
Email Print Friendly Share Subgroup analyses of three pivotal Phase III MONALEESA trials showed Kisqali plus endocrine therapy extended PFS in all patients with and... Read More →
Liberty Property Trust Announces Fourth Quarter 2018 Dividend
/
Date08 Dec 2018
Email Print Friendly Share WAYNE, Pa., Dec. 07, 2018 (GLOBE NEWSWIRE) — Liberty Property Trust (NYSE:LPT) today announced that its board of trustees has declared... Read More →
Oil-Dri Announces First Quarter of Fiscal 2019 Results
/
Date08 Dec 2018
Email Print Friendly Share CHICAGO, Dec. 07, 2018 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, announced... Read More →
Abattis Announces Acquisition of Fertilizer Company NutriVida
/
Date08 Dec 2018
Email Print Friendly Share VANCOUVER, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to... Read More →
Storecoin Announces New Marquee Investors
/
Date08 Dec 2018
Email Print Friendly Share SAN FRANCISCO, CA, Dec. 06, 2018 (GLOBE NEWSWIRE) — (via Blockchain Wire) Zero-fee cryptocurrency Storecoin has announced the participation of two... Read More →
Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select™ in China
/
Date08 Dec 2018
Email Print Friendly Share OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics... Read More →
DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING
/
Date08 Dec 2018
Email Print Friendly Share MINNEAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) — DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX‑V:DMA), a clinical stage biopharmaceutical company, announced today the... Read More →